Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
The effect of exercise and high fat diet on circulating mediators of energy metabolism
EF 2013-14
Résumé
The skeleton is a mineralized connective tissue that is constantly renewed in a process called bone remodeling which consists of consecutive events of bone destruction and new bone formation. Bone remodeling peaks in life during rapid growth and is also increased by exercise which causes an accumulation of bone mass. An osteoblast is a cell responsible for bone formation, and was recently demonstrated to be capable of controlling insulin production and insulin sensitivity of metabolic tissues. Osteoblast does this by producing osteocalcin, which is a small protein capable of binding to the mineral phase of bone during bone formation. Osteocalcin is detached from the mineral and released into the blood during normal bone breakdown process. This specific form of osteocalcin promotes adiponectin to be released from fat tissue, and increases pancreatic í-cells to produce insulin. Adiponectin is an important, positive regulator of cellular insulin sensitivity, fat tissue function, and it decreases and protects from many negative effects of obesity including type 2 diabetes, atherosclerosis, and fatty liver disease. Recent data from our laboratory indicates that plasma fibronectin, secreted by the liver, is capable of regulating í-cell multiplication and insulin sensitivity of fat tissue (unpublished). Plasma fibronectin, a glycoprotein, which forms networks of structural support throughout the body, plays an essential role in cell adhesion during development, production and survival of many cells. Interestingly, our data shows that mice lacking osteocalcin have 70% decrease in plasma fibronectin levels in blood and no detectable fibronectin network in part of the pancreas. Based on these observations, this project, hypothesizes and test the following: 1) Osteocalcin, in addition to its receptor-mediated functions, exerts its effects also via increasing plasma fibronectin production in the liver; 2) Osteocalcin and plasma fibronectin are released in higher levels into blood upon integrating a long-term, continuous exercise routine into life which also promotes accumulation of bone mass and bone remodeling; 3) The increased plasma fibronectin is linked to improved glucose metabolism; 4) High fat diet will decrease plasma fibronectin production, but in combination with exercise (via osteocalcin release from bone), its levels are higher which protects from obesity-linked metabolic disorder (insulin resistance, prediabetes). These hypotheses will be tested in a 20 week-long study where mice will be exposed to aerobic exercise while on a normal or high fat diet (which induces obesity and impairs normal glucose metabolism). Circulating plasma fibronectin, osteocalcin, and adiponectin levels will be measured and correlated to healthy/abnormal glucose and energy metabolism (glucose and tolerance) and pancreatic function (islet size and insulin production). Fat build up into adipose tissue vs. non-metabolic tissues will be assessed as a measure of normal adipose tissue function. Plasma fibronectin levels and distribution will be assessed, and measured in pancreas and adipose tissue of each mouse group. This study has the potential to identify plasma fibronectin as a novel marker of healthy energy metabolism, which thus, may become an important indicator of metabolic health. This study will increase our understanding of blood markers of energy metabolism and will increase our understanding on how organs functions and act on other organs by using blood and plasma as a mediator. This work also has the potential to open new avenues for development of therapies to stimulate plasma fibronectin production to help correct metabolic dysfunctions.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311830
Name
Couldwell Sandrine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The effect of exercise and high fat diet on circulating mediators of energy metabolism
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adiponectin; Adipose Tissue; Bone; Energy Metabolism; Exercise; Obesity; Osteocalcin; Plasma Fibronectin
Abstract
The skeleton is a mineralized connective tissue that is constantly renewed in a process called bone remodeling which consists of consecutive events of bone destruction and new bone formation. Bone remodeling peaks in life during rapid growth and is also increased by exercise which causes an accumulation of bone mass. An osteoblast is a cell responsible for bone formation, and was recently demonstrated to be capable of controlling insulin production and insulin sensitivity of metabolic tissues. Osteoblast does this by producing osteocalcin, which is a small protein capable of binding to the mineral phase of bone during bone formation. Osteocalcin is detached from the mineral and released into the blood during normal bone breakdown process. This specific form of osteocalcin promotes adiponectin to be released from fat tissue, and increases pancreatic í-cells to produce insulin. Adiponectin is an important, positive regulator of cellular insulin sensitivity, fat tissue function, and it decreases and protects from many negative effects of obesity including type 2 diabetes, atherosclerosis, and fatty liver disease. Recent data from our laboratory indicates that plasma fibronectin, secreted by the liver, is capable of regulating í-cell multiplication and insulin sensitivity of fat tissue (unpublished). Plasma fibronectin, a glycoprotein, which forms networks of structural support throughout the body, plays an essential role in cell adhesion during development, production and survival of many cells. Interestingly, our data shows that mice lacking osteocalcin have 70% decrease in plasma fibronectin levels in blood and no detectable fibronectin network in part of the pancreas. Based on these observations, this project, hypothesizes and test the following: 1) Osteocalcin, in addition to its receptor-mediated functions, exerts its effects also via increasing plasma fibronectin production in the liver; 2) Osteocalcin and plasma fibronectin are released in higher levels into blood upon integrating a long-term, continuous exercise routine into life which also promotes accumulation of bone mass and bone remodeling; 3) The increased plasma fibronectin is linked to improved glucose metabolism; 4) High fat diet will decrease plasma fibronectin production, but in combination with exercise (via osteocalcin release from bone), its levels are higher which protects from obesity-linked metabolic disorder (insulin resistance, prediabetes). These hypotheses will be tested in a 20 week-long study where mice will be exposed to aerobic exercise while on a normal or high fat diet (which induces obesity and impairs normal glucose metabolism). Circulating plasma fibronectin, osteocalcin, and adiponectin levels will be measured and correlated to healthy/abnormal glucose and energy metabolism (glucose and tolerance) and pancreatic function (islet size and insulin production). Fat build up into adipose tissue vs. non-metabolic tissues will be assessed as a measure of normal adipose tissue function. Plasma fibronectin levels and distribution will be assessed, and measured in pancreas and adipose tissue of each mouse group. This study has the potential to identify plasma fibronectin as a novel marker of healthy energy metabolism, which thus, may become an important indicator of metabolic health. This study will increase our understanding of blood markers of energy metabolism and will increase our understanding on how organs functions and act on other organs by using blood and plasma as a mediator. This work also has the potential to open new avenues for development of therapies to stimulate plasma fibronectin production to help correct metabolic dysfunctions.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Couldwell, Sandrine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~